中文 | English
Return
Total: 79 , 1/8
Show Home Prev Next End page: GO
Author:( Zhilin LI)

1.Ethical Analysis And Suggestion For Patients With Chronic Renal Failure and Hemodialysis

Zhilin LI

Chinese Medical Ethics 1994;0(06):-

2.Research status of radiotherapy-induced taste disorders in head and neck malignant tumors

Zhilin LI ; Ye ZHANG

Chinese Journal of Radiation Oncology 2021;30(1):95-97

3.Urological complications following renal transplantation

Zhilin NIE ; Qiansheng LI

Chinese Journal of Tissue Engineering Research 2007;0(31):-

4.Research on Drug Release in Vitro of Sirolimus Liposome

Zhilin MIAO ; Zhanquan LI

China Pharmacy 2007;0(25):-

5.Clinical study of navelbine plus paclitaxel for patients with advanced breast cancer

Ping TO ; Zhilin LI ; Hui LI

China Oncology 1998;0(01):-

6.Comparison of short term outcome in the treatment of degenerative lumbar stenosis with Coflex implant versus laminectomy and posterior interbody fusion along with pedicle screw system

Zhilin LI ; Jixian QIAN ; Cunxiao LI

Orthopedic Journal of China 2006;0(11):-

7.Combination chemotherapy with navelbine(NVB) and epirubicin( e-ADM )in treating metastatic breast cancer

Hui LI ; Zhilin LI ; Lamu WU

China Oncology 2000;0(06):-

8.Clinical analysis of the combined chemotherapy with navelbine concurrent with palliative radiotherapy on stage M, nasopharyngeal carcinoma

Zhilin LI ; Jialin YANG ; Jichuan WANG

China Oncology 2000;0(06):-

9.Bilateral chest navel flaps with nerves for repairing the avulsion injury of total hand skin

Zhilin ZHANG ; Zhaoxiang WEI ; Huan LI ;

Chinese Journal of Orthopaedic Trauma 2002;0(03):-

10.Investigation on autologous coronary intervention in patients with angina recurrence of graft vessels occlusion after coronary artery bypass graftting

Chengyang LI ; Zhilin MIAO ; Zhanquan LI ; Na DUAN ; Defeng LUO

Chinese Journal of Primary Medicine and Pharmacy 2011;18(z1):1-2

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 79 , 1/8 Show Home Prev Next End page: GO